Ungericht, M; Messner, M; Puelacher, C; Schuetz, T; Staggl, S; Zaruba, MM; Willenbacher, W; Weger, R; Rittler, S; Agis, H; Krauth, MT; Weber, T; Höller, V; Verheyen, N; Ebner, C; Strassl, I; Pichler, P; Darling, P; Pölzl, G
Prevalence and outcome of coronary artery disease in cardiac amyloidosis: a retrospective Austrian multicenter study
AMYLOID. 2024; 31: S147-S147.
[Poster]
Web of Science
Lugitsch, J; Hoeller, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
Lugitsch, J; Holler, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
WIEN KLIN WOCHENSCHR. 2023; 135: S472-S473.
[Poster]
Web of Science
FullText
Schwegel, N; Riepl, H; Spath, J; Kolesnik, E; Zach, D; Santner, V; Holler, V; Obermayer-Pietsch, B; Schmid, J; Scherr, D; von Lewinski, D; Zirlik, A; Ablasser, K; Verheyen, N
Role of Comorbidities in Chronic Heart Failure-a prospective cohort study
WIEN KLIN WOCHENSCHR. 2023; 135: S477-S477.
Web of Science
FullText
Willenbacher, W; Agis, H; Krauth, MT; Rodriguez-Torres, C; Strassl, I; Verheyen, ND; Hoeller, V; Darling, P; Pichler, P; Rittler, S; Weger, R; Willenbacher, E
Real-World Outcomes and Treatment Patterns in AL-Amyloidosis in Austria: An Analysis from the Austrian Interdisciplinary Amyloidosis Registry (AIDA)
BLOOD. 2023; 142:
Doi: 10.1182/blood-2023-187598
Web of Science
FullText
FullText_MUG
Zach, D; Schwegel, N; Hoeller, V; Kolesnik, E; Gollmer, J; Reiter, U; Seggewiss, H; Batzner, A; Zirlik, A; Rainer, P; Ablasser, K; Verheyen, N
Comparing indices of systemic inflammation and cardiac phenotype between hypertensive and non-hypertensive hypertrophic cardiomyopathy
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
Zach, D; Schwegel, N; Holler, V; Kolesnik, E; Gollmer, J; Reiter, U; Seggewiss, H; Batzner, A; Zirlik, A; Rainer, P; Ablasser, K; Verheyen, N
Comparing indices of systemic inflammation and cardiac phenotype in hypertensive and non-hypertensive hypertrophic cardiomyopathy
WIEN KLIN WOCHENSCHR. 2023; 135: S475-S476.
[Poster]
Web of Science
FullText
Grubler, M; Zach, D; Holler, V; Seebacher, HA; Verheyen, N
A rare genetic cause of left ventricular hypertrophy and heart failure with preserved ejection fraction
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2):129-129.
[Poster]
Web of Science
Verheyen, N; Ungericht, M; Paar, L; Danninger, K; Schneiderbauer-Porod, S; Duca, F; Cherouney, B; Holler, V; Ablasser, K; Zach, D; Kiblbock, D; Frick, M; Bonderman, D; Dierneder, J; Ebner, C; Weber, T; Polzl, G
Diagnostic accuracy of amyloid scintigraphy for the histopathological diagnosis of cardiac transthyretin amyloidosis-a retrospective Austrian multicenter study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2): 89-90.
[Poster]
Web of Science
Verheyen, N; Ungericht, M; Paar, L; Danninger, K; Schneiderbauer-Porod, S; Duca, F; Hoeller, V; Ablasser, K; Kiblboeck, D; Frick, M; Bonderman, D; Dierneder, J; Ebner, C; Weber, T; Poelzl, G
Diagnostic accuracy of amyloid scintigraphy for the histopathological diagnosis of cardiac transthyretin amyloidosis - a retrospective Austrian multicenter study
EUR HEART J. 2022; 43: 903-903.
Web of Science
Holler, V; Zach, D; Kolesnik, E; Wallner, M; Fruhwald, F; Rainer, P; Zirlik, A; Verheyen, N
Proportions and temporal trends of diseases leading to a hypertrophic cardiomyopathy phenotype. a prospective single-center cohort study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 3):S98-S98.
[Onlinepräsentation]
Web of Science